MedTrace Logo

Hypophosphatemic Rickets in Norway

NCT01057186 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-08-31

No results posted yet for this study

Summary

The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.

Conditions

  • Hypophosphatemia, Familial
  • Rickets
  • Hyperphosphatemia

Interventions

DIETARY_SUPPLEMENT

Alfacalcidol; phosphate.

Individual dosage form and dosage depending on phenotype and underlying cause.

DRUG

Sevelamer

Pills. Individual dosage depending on clinical symptoms/phenotype.

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Robert Bjerknes, Professor, MD, PhD · Haukeland University Hospital, Pediatric department

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2018-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01057186 on ClinicalTrials.gov